Type One Diabetes Completed Phase 1 Trials for Insulin detemir (DB01307)

Back to Type One Diabetes

Also known as: Diabetes Mellitus, Juvenile-Onset / T1DM - Type 1 Diabetes Mellitus / Diabetes Type I / Type I Diabetes / Type1 Diabetes / Diabetes Type One / Diabete Type 1 / Type One Diabetes Mellitus / Diabetics Mellitus Type 1 / Type 1 Diabetes / Type 1 Diabetes Mellitus (T1DM) / Insulin-Dependent Diabetes Mellitus 1 / Type1diabetes / Diabetes Mellitus Type I / Type1 Diabetes Mellitus / Type 1 Diabetes (T1D) / Diabetes Mellitus Type 1 / Juvenile Onset Diabetes Mellitus / Diabetes Type 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Type I Diabetes Mellitus / Diabetes Mellitus, Sudden-Onset / Type-1 Diabetes Mellitus / Insulin Dependent Diabetes Mellitus 1 / Type 1 Diabetes Mellitus / Juvenile-Onset Diabetes / Diabetes Mellitus, Insulin-Dependent, 1 / Diabetes mellitus type 1 (disorder) / Diabetes mellitus: [juvenile] or [insulin dependent] / Juvenile diabetes / Insulin dependent diabetic / IDDM / Diabetes mellitus insulin-dependent / Insulin-dependent diabetes mellitus / Diabetes mellitus juvenile onset / Immune-mediated diabetes / Insulin dependent diabetes mellitus / Insulin dependent diabetes mel / IDDM - Insulin-dependent diabetes mellitus / Diabetes mellitus - juvenile / Ketosis-prone diabetes mellitus (disorder) / Ketosis-prone diabetes mellitus

Indication	Status	Phase
DBCOND0076728 (Type One Diabetes)	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00652288	Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs	Treatment	Insulin aspart (DB01306) Insulin detemir (DB01307) Insulin glargine (DB00047) Insulin human (DB00030) Insulin lispro (DB00046)
NCT06685185	A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) Insulin detemir (DB01307) NNC0363-1063 (DB26327)
NCT05134987	A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works	Treatment	Insulin detemir (DB01307) NNC0363-0845 (DB29350)
NCT00760448	Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia	Treatment	Insulin detemir (DB01307) Insulin human (DB00030)
NCT01542450	Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes	Treatment	Insulin detemir (DB01307) Insulin human (DB00030)
NCT01497574	Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes	Treatment	Insulin detemir (DB01307) Insulin glargine (DB00047)
NCT01135927	A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes	Treatment	Insulin degludec (DB09564) Insulin detemir (DB01307)
NCT00810589	A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial	Treatment	Insulin detemir (DB01307) Insulin human (DB00030) Insulin lispro (DB00046)